- John Mendlein
Dr. John Mendlein is a
biotechexecutive and currently CEOof Adnexus Therapeutics, a Boston, MA based biotechcompany. He was formerly CEO of Affinium Pharmaceuticals.
Under Dr. Mendlein's leadership, Adnexus was acquired by Bristol Myers Squibbs for roughly US$400M.
* [http://www.adnexustx.com/news/2005_0615.php] home page of Adnexus
* [http://www.flagshipventures.com/news/06152005p.html] bio on Flagship Ventures website
Wikimedia Foundation. 2010.